PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Diagnostic centers - Market size and forecast 2018-2023 Hospitals and clinics - Market size and forecast 2018-2023 Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY TYPE HIV rapid immunoassay test HIV rapid molecular diagnostic test PART 09: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS Efforts to increase pre-marital screenings for HIV Increasing clinical studies by researchers and promotional activities by manufacturers Availability of a broad range of HIV rapid test kits by vendors PART 13: VENDOR LANDSCAPE Overview Landscape disruption PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott Laboratories Bio-Rad Laboratories Inc. Danaher Corp. F. Hoffmann-La Roche Ltd. QIAGEN Group PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 16: EXPLORE TECHNAVIO LOE Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Diagnostic centers - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Diagnostic centers - Year-over-year growth 2019-2023 (%) Exhibit 21: Hospitals and clinics - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Hospitals and clinics - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by end-user Exhibit 24: Customer landscape Exhibit 25: Market share of global human immunodeficiency virus (HIV) rapid test kits market by test type 2018 Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Impact of drivers and challenges Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Abbott Laboratories - Vendor overview Exhibit 45: Abbott Laboratories - Business segments Exhibit 46: Abbott Laboratories - Organizational developments Exhibit 47: Abbott Laboratories - Geographic focus Exhibit 48: Abbott Laboratories - Segment focus Exhibit 49: Abbott Laboratories - Key offerings Exhibit 50: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 51: Bio-Rad Laboratories Inc. - Business segments Exhibit 52: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 53: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 54: Bio-Rad Laboratories Inc. - Segment focus Exhibit 55: Bio-Rad Laboratories Inc. - Key offerings Exhibit 56: Danaher Corp. - Vendor overview Exhibit 57: Danaher Corp. - Business segments Exhibit 58: Danaher Corp. - Organizational developments Exhibit 59: Danaher Corp. - Geographic focus Exhibit 60: Danaher Corp. - Segment focus Exhibit 61: Danaher Corp. - Key offerings Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 68: QIAGEN Group - Vendor overview Exhibit 69: QIAGEN Group - Product segments Exhibit 70: QIAGEN Group - Organizational developments Exhibit 71: QIAGEN Group - Geographic focus Exhibit 72: QIAGEN Group - Segment focus Exhibit 73: QIAGEN Group - Key offerings Exhibit 74: Validation techniques employed for market sizing Exhibit 75: Definition of market positioning of vendors    

Abbott Laboratories Bio-Rad Laboratories Inc. Danaher Corp. F. Hoffmann-La Roche Ltd. QIAGEN Group